scholarly journals Progressive Primary Appendiceal Crohn’s Disease in a 21-Year-old Female

2020 ◽  
Vol 14 (3) ◽  
pp. 504-509
Author(s):  
Cullen Roberts ◽  
Jason L. Hornick ◽  
Vanessa Mitsialis ◽  
James Yoo

Crohn’s disease is an inflammatory bowel disorder that can affect any portion of the gastrointestinal tract, most commonly the terminal ileum near the ileocecal valve. Crohn’s disease can be characterized by transmural inflammation and deep fissuring ulcers that predispose to fistula formation and “skip” lesions separated by normal segments of bowel. While often affecting the terminal ileum near the ileocecal valve, Crohn’s disease presenting primarily in the appendix is a rare entity. In part due to its low prevalence, cases of appendiceal Crohn’s disease can be confused for acute, non-Crohn’s-related appendicitis on initial presentation. Although there are published cases of primary appendiceal Crohn’s disease in the medical literature, in most cases the diagnosis is made retrospectively following appendectomy for presumed appendicitis. We report on a case of Crohn’s disease that was diagnosed pre-operatively, primarily involved the appendix, and which progressed radiographically despite medical therapy and resolution of clinical symptoms. Unique management issues related to this case include the appropriateness of systemic therapy for disease isolated to the appendix, an inability to endoscopically obtain tissue for a definitive diagnosis, and the decision to proceed with surgery in an asymptomatic patient with progressive disease on imaging. Intraoperatively, the appendix was severely inflamed and densely adherent to the left pelvic side wall and adjacent to the left ovary and fallopian tube. A laparoscopic appendectomy was performed. Pathology demonstrated acute appendicitis as well as marked mural chronic inflammation and epithelioid granulomas, consistent with Crohn’s disease. Surgical resection may be the most appropriate treatment for Crohn’s disease primarily involving the appendix, obviating the need for systemic therapy and minimizing the risk for appendiceal perforation and fistula formation.

2009 ◽  
Vol 3 (4) ◽  
pp. 287-290 ◽  
Author(s):  
Tamás Molnár ◽  
Klaudia Farkas ◽  
Ferenc Nagy ◽  
Zoltán Szepes ◽  
László Tiszlavicz ◽  
...  

2001 ◽  
Vol 15 (5) ◽  
pp. 337-340 ◽  
Author(s):  
Donald H Taves ◽  
Linda Probyn

Lesions in the terminal ileum are often difficult to visualize on routine small bowel follow-through (SBFT) and may require further investigation to rule out associated abnormalities in the ileocecal valve or cecum. This may be done by peroral pneumocolon at the same sitting as the SBFT, but may require bowel preparation. Two cases of cecal carcinoma that were initially diagnosed as Crohn's disease on SBFT without further investigation of the cecum are reported.


2009 ◽  
Vol 47 (05) ◽  
Author(s):  
K Farkas ◽  
T Molnár ◽  
F Nagy ◽  
Z Szepes ◽  
L Tiszlavicz ◽  
...  

2009 ◽  
Vol 3 (1) ◽  
pp. S39
Author(s):  
K. Farkas ◽  
T. Molnár ◽  
F. Nagy ◽  
Z.G. Szepes ◽  
L. Tiszlavicz ◽  
...  

2021 ◽  
Vol 12 (1) ◽  
pp. 56-66
Author(s):  
Toumi Ryma ◽  
Arezki Samer ◽  
Imene Soufli ◽  
Hayet Rafa ◽  
Chafia Touil-Boukoffa

Inflammatory Bowel Disease (IBD) is a term used to describe a group of complex disorders of the gastrointestinal (GI) tract. IBDs include two main forms: Crohn’s Disease (CD) and Ulcerative Colitis (UC), which share similar clinical symptoms but differ in the anatomical distribution of the inflammatory lesions. The etiology of IBDs is undetermined. Several hypotheses suggest that Crohn’s Disease and Ulcerative Colitis result from an abnormal immune response against endogenous flora and luminal antigens in genetically susceptible individuals. While there is no cure for IBDs, most common treatments (medication and surgery) aim to reduce inflammation and help patients to achieve remission. There is growing evidence and focus on the prophylactic and therapeutic potential of probiotics in IBDs. Probiotics are live microorganisms that regulate the mucosal immune system, the gut microbiota and the production of active metabolites such as Short-Chain Fatty Acids (SCFAs). This review will focus on the role of intestinal dysbiosis in the immunopathogenesis of IBDs and understanding the health-promoting effects of probiotics and their metabolites.


BMC Cancer ◽  
2005 ◽  
Vol 5 (1) ◽  
Author(s):  
Ugo Cioffi ◽  
Matilde De Simone ◽  
Stefano Ferrero ◽  
Michele M Ciulla ◽  
Alessandro Lemos ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document